SCHEMBL1064512

SCHEMBL1064512

CCCCOOC(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1526422 0.93 NAAA (0.45)
SCHEMBL28816424 0.91 NAAA (0.48)
SCHEMBL9461649 0.91 NAAA (0.48)
Hydrochloric Acid SCHEMBL11524169 0.91 NAAA (0.43)
SCHEMBL8512927 0.91 NAAA (0.48)
SCHEMBL3004605 0.91 NAAA (0.48)
SCHEMBL3877437 0.86 ALDH1A1 (0.43)
SCHEMBL28439909 0.84
SCHEMBL3155224 0.82 ALDH1A1 (0.48)
Bicarbonate SCHEMBL1538407 0.81 ALDH1A1 (0.52)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 89 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1017770-A4 AQUEOUS RINSING COMPOSITION ARCH SPEC CHEM INC (US) 2002-04-24 EP claimed
EP-1017770-A1 AQUEOUS RINSING COMPOSITION ARCH SPECIALTY CHEMICALS, INC. (US) 2000-07-12 EP claimed
WO-1999015609-A1 AQUEOUS RINSING COMPOSITION ARCH SPECIALTY CHEMICALS, INC. (US) 1999-04-01 WO claimed
WO-2024006425-A1 ADHESIVE COMPOSITIONS CONTAINING MAGNETIC PARTICLES UNIVERSITY OF KANSAS (US) 2024-01-04 WO disclosed
WO-2023220986-A1 MICROCRACK STRAIN SENSOR AND PREPARATION METHOD THEREFOR 中山旺材科技有限公司 2023-11-23 WO disclosed
US-11333976-B2 Resin, photosensitive resin composition, electronic component and display device using the same TORAY INDUSTRIES, INC. (JP) 2022-05-17 US disclosed
CN-107406590-B Resin, photosensitive resin composition, and electronic component and display device using the same 东丽株式会社 2020-08-04 CN disclosed
EP-3148500-A1 ORAL CARE COMPOSITIONS HAVING IMPROVED STABILITY The Procter & Gamble Company (US) 2017-04-05 EP disclosed
WO-2015172323-A1 ORAL CARE COMPOSITIONS HAVING IMPROVED STABILITY THE PROCTER & GAMBLE COMPANY (US) 2015-11-19 WO disclosed
EP-1805319-B1 RECOMBINANT HUMAN T2 RNASE AND USES THEREOF YISSUM RES DEV CO (IL) 2014-09-03 EP disclosed
US-8735127-B2 Methods of and compositions for inhibiting the proliferation of mammalian cells YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) 2014-05-27 US disclosed
EP-0636145-A1 SYNTHETIC POLYPEPTIDES DERIVED FROM THE HIV ENVELOPE GLYCOPROTEIN PROTEUS MOLECULAR DESIGN LIMITED (GB) 1995-02-01 EP disclosed
EP-0616613-A1 FRAGMENTS OF PRION PROTEINS PROTEUS MOLECULAR DESIGN LIMITED (GB) 1994-09-28 EP disclosed
WO-1993021218-A1 SYNTHETIC POLYPEPTIDES DERIVED FROM THE HIV ENVELOPE GLYCOPROTEIN PROTEUS MOLECULAR DESIGN LIMITED (GB) 1993-10-28 WO disclosed
WO-1993011155-A1 FRAGMENTS OF PRION PROTEINS PROTEUS MOLECULAR DESIGN LIMITED (GB) 1993-06-10 WO disclosed
EP-0519986-A1 SYNTHETIC POLYPEPTIDES PROTEUS MOLECULAR DESIGN LIMITED (GB) 1992-12-30 EP disclosed
WO-1991013909-A1 SYNTHETIC POLYPEPTIDES PROTEUS MOLECULAR DESIGN LIMITED (GB) 1991-09-19 WO disclosed
EP-0371046-A1 SYNTHETIC PEPTIDES RELATED TO HIV-ENV PROTEINS PROTEUS MOLECULAR DESIGN LIMITED (GB) 1990-06-06 EP disclosed
EP-0298633-A2 Synthetic polypeptides PROTEUS MOLECULAR DESIGN LIMITED (GB) 1989-01-11 EP disclosed
WO-1988010267-A1 SYNTHETIC PEPTIDES RELATED TO HIV-ENV PROTEINS PROTEUS BIOTECHNOLOGY LIMITED (GB) 1988-12-29 WO disclosed